The Department of Health and Human Services is the Federal government's principal agency for protecting the health of all Americans and providing essential human services, especially to those who are least able to help themselves.
Fiscal Year 2008: No Current Data Available Fiscal Year 2009: No Current Data Available Fiscal Year 2010: In fiscal year 2010, projected to issue 53 awards to reduce Chronic Disease risk
factors, prevent and delay chronic disease, promote wellness, and better manage
chronic conditions. This initiative will address the following:
ÃƒÆ’Ã†â€™Ãƒâ€šÃ‚Â¢ÃƒÆ’Ã‚Â¢ÃƒÂ¢Ã¢â€šÂ¬Ã…Â¡Ãƒâ€šÃ‚Â¬ÃƒÆ’Ã¢â‚¬Å¡Ãƒâ€šÃ‚Â¢ Increased levels of physical activity
ÃƒÆ’Ã†â€™Ãƒâ€šÃ‚Â¢ÃƒÆ’Ã‚Â¢ÃƒÂ¢Ã¢â€šÂ¬Ã…Â¡Ãƒâ€šÃ‚Â¬ÃƒÆ’Ã¢â‚¬Å¡Ãƒâ€šÃ‚Â¢ Improved nutrition (e.g. increased fruit/vegetable consumption, reduced
salt and transfats);
ÃƒÆ’Ã†â€™Ãƒâ€šÃ‚Â¢ÃƒÆ’Ã‚Â¢ÃƒÂ¢Ã¢â€šÂ¬Ã…Â¡Ãƒâ€šÃ‚Â¬ÃƒÆ’Ã¢â‚¬Å¡Ãƒâ€šÃ‚Â¢ Decreased smoking prevalence and decreased teen smoking initiation; and
ÃƒÆ’Ã†â€™Ãƒâ€šÃ‚Â¢ÃƒÆ’Ã‚Â¢ÃƒÂ¢Ã¢â€šÂ¬Ã…Â¡Ãƒâ€šÃ‚Â¬ÃƒÆ’Ã¢â‚¬Å¡Ãƒâ€šÃ‚Â¢ Decreased exposure to secondhand smoke.
ÃƒÆ’Ã†â€™Ãƒâ€šÃ‚Â¢ÃƒÆ’Ã‚Â¢ÃƒÂ¢Ã¢â€šÂ¬Ã…Â¡Ãƒâ€šÃ‚Â¬ÃƒÆ’Ã¢â‚¬Å¡Ãƒâ€šÃ‚Â¢ Expand National Network of Tobacco Quitlines.
Uses and Use Restrictions
Of the $650 million, $128.1 million will support States and Territories in
promoting wellness and preventing chronic disease through state-wide and local policy and environmental change for chronic disease prevention and to expand tobacco quit lines and tobacco counter advertising.
This program will support evidence-based policies and interventions at the state and local levels which ultimately help change social norms and make healthier choices easier and more affordable.
Programs will focus on policy and environmental changes that both improve statewide policies and support community efforts for chronic disease prevention and control described in Section "0.50" above.
The use of and use restrictions are as follows: ÃƒÆ’Ã†â€™Ãƒâ€šÃ‚Â¢ÃƒÆ’Ã‚Â¢ÃƒÂ¢Ã¢â€šÂ¬Ã…Â¡Ãƒâ€šÃ‚Â¬ÃƒÆ’Ã¢â‚¬Å¡Ãƒâ€šÃ‚Â¢ Recipients may only expend funds for reasonable program purposes, including personnel, travel, supplies, and services, such as contractual to support policy and system changes to reduce chronic disease risk factors, prevent and delay chronic disease, promote wellness, and better manage chronic conditions in the following areas; to increased levels of physical activity, improved nutrition (e.g.
increased fruit/vegetable consumption, reduced salt and transfats); decreased smoking prevalence and decreased teen smoking initiation; and to decreased exposure to secondhand smoke.
ÃƒÆ’Ã†â€™Ãƒâ€šÃ‚Â¢ÃƒÆ’Ã‚Â¢ÃƒÂ¢Ã¢â€šÂ¬Ã…Â¡Ãƒâ€šÃ‚Â¬ÃƒÆ’Ã¢â‚¬Å¡Ãƒâ€šÃ‚Â¢ To support a core infrastructure for the delivery of quitline services which include proactive counseling and promotion/outreach.
Proactive quitlines exist when a trained counselor telephones the smokers to provide support in initiating a quit attempt and maintaining prolonged abstinence.
ÃƒÆ’Ã†â€™Ãƒâ€šÃ‚Â¢ÃƒÆ’Ã‚Â¢ÃƒÂ¢Ã¢â€šÂ¬Ã…Â¡Ãƒâ€šÃ‚Â¬ÃƒÆ’Ã¢â‚¬Å¡Ãƒâ€šÃ‚Â¢ Funds may be used to expand and promote proactive counseling capacity, enhance and expand integration of online and other electronic information support technologies, expand media and marketing efforts, extend hours of service, expand outreach to specific populations, provide multiple language services, increase collaborations with healthcare systems and providers, and for evaluation.
ÃƒÆ’Ã†â€™Ãƒâ€šÃ‚Â¢ÃƒÆ’Ã‚Â¢ÃƒÂ¢Ã¢â€šÂ¬Ã…Â¡Ãƒâ€šÃ‚Â¬ÃƒÆ’Ã¢â‚¬Å¡Ãƒâ€šÃ‚Â¢ Purchase of Nicotine Replacement Therapy medications is authorized with these funds.
FDA-approved Nicotine Replacement Therapy (e.g., nicotine patch, gum, nasal spray, inhaler, and lozenge) is proven effective in helping people quit smoking.
ÃƒÆ’Ã†â€™Ãƒâ€šÃ‚Â¢ÃƒÆ’Ã‚Â¢ÃƒÂ¢Ã¢â€šÂ¬Ã…Â¡Ãƒâ€šÃ‚Â¬ÃƒÆ’Ã¢â‚¬Å¡Ãƒâ€šÃ‚Â¢ Recipients may not use funds for research.
ÃƒÆ’Ã†â€™Ãƒâ€šÃ‚Â¢ÃƒÆ’Ã‚Â¢ÃƒÂ¢Ã¢â€šÂ¬Ã…Â¡Ãƒâ€šÃ‚Â¬ÃƒÆ’Ã¢â‚¬Å¡Ãƒâ€šÃ‚Â¢ Recipients may not use funds for clinical care.
ÃƒÆ’Ã†â€™Ãƒâ€šÃ‚Â¢ÃƒÆ’Ã‚Â¢ÃƒÂ¢Ã¢â€šÂ¬Ã…Â¡Ãƒâ€šÃ‚Â¬ÃƒÆ’Ã¢â‚¬Å¡Ãƒâ€šÃ‚Â¢ Recipients may not generally use HHS/CDC/ATSDR funding for the purchase of furniture or equipment.
Any such proposed spending must be identified in the budget.
ÃƒÆ’Ã†â€™Ãƒâ€šÃ‚Â¢ÃƒÆ’Ã‚Â¢ÃƒÂ¢Ã¢â€šÂ¬Ã…Â¡Ãƒâ€šÃ‚Â¬ÃƒÆ’Ã¢â‚¬Å¡Ãƒâ€šÃ‚Â¢ The recipient must perform a substantial role in carrying out project objectives and not merely serve as a conduit for an award to another party or provider who is ineligible.
ÃƒÆ’Ã†â€™Ãƒâ€šÃ‚Â¢ÃƒÆ’Ã‚Â¢ÃƒÂ¢Ã¢â€šÂ¬Ã…Â¡Ãƒâ€šÃ‚Â¬ÃƒÆ’Ã¢â‚¬Å¡Ãƒâ€šÃ‚Â¢ Recipients may not spend more than 10 percent of the total award on nicotine replacement therapy.
Government - General: Health/Medical
State; Local; U.S. Territories
Applicants should document the need for assistance, state the objectives of the project, outline the method of operation, describe the evaluation procedures, describe plans for sustaining the impact of ARRA investments beyond the federal funding provided in the next two years and provide a budget with justification of
funds requested. Costs will be determined in accordance with OMB Circular No. A-87 for State and local governments. OMB Circular No. A-87 applies to this program.
Aplication and Award Process
Preapplication coordination is not applicable.
Environmental impact information is not required for this program.
This program is excluded from coverage under E.O.
OMB Circular No. A-102 applies to this program. This program is excluded from coverage under OMB Circular No. A-110. Applicants must download the SF424 application forms through Grants.gov/Apply. Only the forms package directly attached to a specific Funding Opportunity Announcement (FOA) can be used. If an applicant does not have access to the Internet, or if they have difficulty accessing the forms online, contact the CDC Procurement and Grants Office Technical Information Management Section (PGOTIMS) staff. For this, or further assistance, contact PGO TIMS: Telephone (770) 488-2700, Email: PGOTIM@cdc.gov. HHS/CDC Telecommunications for the hearing impaired: TTY (770) 488-2783.
All applications that are complete and esponsive to non-competitive supplemental grant announcements will e evaluated for scientific and technical merit and receive support. Support will e need and formula based and demonstrated capacity to accomplish the activities listed in the supplemental announcement. Successful applicants will receive a Notice of Award (NOA)
from the CDC Procurement and Grants Office. The NOA shall be the only binding, authorizing document between the recipient and CDC. The NOA will be
signed by an authorized Grants Management Officer.
Contact the headquarters or regional office, as appropriate, for application deadlines.
This program is authorized under sections 301(a), 307, 310, 3111 and 317(k) (2) American Recovery and Reinvestment Act of 2009 (ARRA) [Public Law 111.5], Public Health Service Act, 42 U.S. Code 241(a) and 247b (k) 2, and the Comprehensive Smoking Education Act of 1984, Comprehensive Smokeless Tobacco Health Education Act of 1986.
Range of Approval/Disapproval Time
Formula and Matching Requirements
This program has no statutory formula.
This program has no matching requirements.
This program does not have MOE requirements.
Length and Time Phasing of Assistance
Project Period: until October 30, 2012. Method of awarding/releasing assistance: lump sum.
Post Assistance Requirements
Recipients of Federal awards from funds authorized under Division A of the
ARRA must comply with all requirements specified in Division A of the ARRA (Public Law 111-5), including reporting requirements outlined in Section 1512 of
For purposes of reporting, ARRA recipients must report on ARRA sub-recipient (sub-grantee and sub-contractor) activities as specified below.
Not later than 10 days after the end of each calendar quarter, starting with the quarter ending June 30, 2009 and reporting by July 10, 2009, the recipient must submit quarterly reports to HHS that will be posted to Recovery.gov, containing the following information: (a)The total amount of ARRA funds under this award; (b) The amount of ARRA
funds received under this award that were obligated and expended to projects or activities; (c) The amount of unobligated award balances; (d) A detailed list of all projects or activities for which ARRA funds under this award were obligated and expended, including: (1) the name of the project or activity; (2) a description of the project or activity; (3) an evaluation of the completion status of the project or
activity; (4) an estimate of the number of jobs created and the number of jobs
retained by the project or activity; and (5) for infrastructure investments made by State and local governments, the purpose, total cost, and rationale of the agency for funding the infrastructure investment with funds made available under this Act, and the name of the person to contact at the agency if there are concerns with the infrastructure investment; (e) Detailed information on any sub-awards (sub-contracts or sub-grants) made by the grant recipient to include the data elements required to comply with the Federal Funding Accountability and Transparency Act of 2006 (Public Law 109-282).
For any sub-award equal to or larger than $25,000, the following information will be required: (1) the name of the entity
receiving the sub-award; (2) the amount of the sub-award; (3) the transaction
type; (4) the North American Industry Classification System code or Catalog of
Federal Domestic Assistance (CFDA) number; (5) program source; (6) an award title descriptive of the purpose of each funding action; (7) the location of the entity receiving the award; (8) the primary location of performance under the award, including the city, State, congressional district, and country; and (9) a unique identifier of the entity receiving the award and of the parent entity of the recipient, should the entity be owned by another entity.
(f) All sub-awards less than $25,000 or to individuals may be reported in the aggregate, as prescribed by HHS.
(g) Recipients must account for each ARRA award and sub-award (sub-grant and sub-contract) separately.
Recipients will draw down ARRA funds on an award-specific basis.
Pooling of ARRA award funds with other funds for drawdown or other purposes is not permitted.
(h) Recipients must account for each ARRA award separately by referencing the assigned CFDA number for each award.
Additional reporting requirements will be detailed in Funding Opportunity Announcements and included in the award notice.
Final financial status and performance reports are required 90 days after the end of the project period.
No cash reports are required.
No progress reports are required.
No expenditure reports are required.
No performance monitoring is required.
In accordance with the provisions of OMB Circular No. A-133 (Revised, June 27, 2003), "Audits of States, Local Governments, and Non-Profit Organizations," nonfederal entities that expend financial assistance of $500,000 or more in Federal awards will have a single or a program-specific audit conducted for that year. Nonfederal entities that expend less than $500,000 a year in Federal awards are exempt from Federal audit requirements for that year, except as noted in Circular No. A-133. In accordance with the provisions of OMB Circular No. A-133 (Revised, June 27, 2003), "Audits of States, Local Governments, and Non-Profit Organizations," nonfederal entities that expend financial assistance of $500,000 or more in Federal awards will have a single or a program-specific audit conducted for that year. Nonfederal entities that expend less than $500,000 a year in Federal awards are exempt from Federal audit requirements for that year, except as noted in Circular No. A-133. An organization that expends $500,000 or more in a year in Federal awards shall have a single or program-specific audit conducted for that year in accordance with the provisions of OMB Circular A-133, Audit of States, Local Governments, and Non-Profit Organizations
Financial records, supporting documents, statistical records, and all other records pertinent to the grant program must be kept readily available for review by personnel authorized to examine PHS grant accounts. Financial records, supporting documentation, statistical records, and all other records pertinent to an award shall be retained for a minimum of 3 years, or until completion and resolution of any audit in process or pending resolution. In all cases records must be retained until resolution of any audit questions. Property records must be retained in accordance with 45 CFR 92.42 requirements.
(Cooperative Agreements (Discretionary Grants)) FY 08 $0; FY 09 est $104,962,630; FY 10 est $128,000,000
Range and Average of Financial Assistance
Component 1 (State Chronic Disease Policy and System Change - $300,000 to 3.9 million
Component 2 (Tobacco Quitline) - $100,000 to 3.2 million.
Regulations, Guidelines, and Literature
Code of Federal Regulations 45 CFR Part 92
Regional or Local Office
Kevin Collins 1600 Clifton Road, NE.
, Atlanta, Georgia 30333 Email: KTCollins@cdc.gov Phone: 770-488-1218 Fax: 770-488-1218
Criteria for Selecting Proposals
Funding would be specifically directed to state and local health departments for Evidenced-Based Clinical and Community-Based Prevention and Wellness activities. CDC will require state applicants to specifically address in their applications state plans for sustaining the impact of ARRA investments beyond the federal funding provided in the next two years. Specifically, states will need to demonstrate a continued plan for progress toward meeting HHS Action Plan prevention targets as demonstrated through reporting metrics outlined in the Plan. Other criteria will be listed in individual funding opportunity announcements.
Dr. Rajiv Shah, the Administrator of the U.S. Agency for International Development (USAID) leads the U.S. government’s efforts to end extreme poverty. He chose to participate in the impact investing conference at the Vatican and met with Pope Francis directly to address world poverty, the future of impact investing, and promotion of resilient, vibrant democratic societies worldwide.